Phase II trial of weekly docetaxel and gemcitabine as first-line therapy for patients with advanced non-small cell lung cancer

By Kalmadi Sujith   McNeill Giles   Davis Mellar   Peereboom David   Adelstein David   Mekhail Tarek  

Medical Oncology, Vol. 23, Iss. 4, 2006-12 ,pp. : 507-513

Humana Press, Inc

Access to resources Recommend Favorite

Biweekly administration of gemcitabine and vinorelbine as first line therapy in elderly advanced breast cancer

By Dinota Angelo   Bilancia Domenico   Romano Rosangela   Manzione Luigi  

Breast Cancer Research and Treatment, Vol. 89, Iss. 1, 2005-01 ,pp. : 1-3

Springer Publishing Company

Access to resources Recommend Favorite

Phase II Study of Gemcitabine and Erlotinib as Adjuvant Therapy for Patients with Resected Pancreatic Cancer

By Bao Philip   Ramanathan Ramesh   Krasinkas Alyssa   Bahary Nathan   Lembersky Barry   Bartlett David   Hughes Steven   Lee Kenneth   Moser A.   Zeh Herbert  

Annals of Surgical Oncology, Vol. 18, Iss. 4, 2011-04 ,pp. : 1122-1129

Springer Publishing Company

Access to resources Recommend Favorite

Trastuzumab and gemcitabine as salvage therapy in heavily pre-treated patients with metastatic breast cancer

By Bartsch Rupert   Wenzel Catharina   Gampenrieder Simon   Pluschnig Ursula   Altorjai Gabriela   Rudas Margaretha   Mader Robert   Dubsky Peter   Rottenfusser Andrea   Gnant Michael   Zielinski Christoph   Steger Guenther  

Cancer Chemotherapy and Pharmacology, Vol. 62, Iss. 5, 2008-10 ,pp. : 903-910

Springer Publishing Company

Access to resources Recommend Favorite

Phase II Trial of Gemcitabine plus Cisplatin Repeating Doublet Therapy in Previously Treated, Relapsed Ovarian Cancer Patients

By Nagourney R.A.   Brewer C.A.   Radecki S.   Kidder W.A.   Sommers B.L.   Evans S.S.   Minor D.R.   DiSaia P.J.  

Gynecologic Oncology, Vol. 88, Iss. 1, 2003-01 ,pp. : 35-39

Academic Press

Access to resources Recommend Favorite